STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: On November 13, 2007, Orexo AB (publ) (STO:ORX) held an extraordinary shareholders’ meeting at 10.00 am in Stockholm. Resolution regarding authorization for the board of directors to resolve to issue new shares The shareholders’ meeting resolved to authorize the board of directors to resolve to issue, in connection with the acquisition of Biolipox AB and without preferential rights for the shareholders, at one or more occasions, not more than 8,560,000 new shares and to issue warrants. The company’s share capital could be increased by not more than SEK 3,424,000 as a consequence of such issues of shares and warrants. Payment for the newly issued shares shall be made in kind, consisting of shares and options of Biolipox. The authorization shall be valid not longer than until the next annual shareholders’ meeting.
